Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
9.95 USD | +1.22% | +0.20% | -29.08% |
Apr. 02 | Goldman Sachs Initiates Olema Pharmaceuticals at Buy With $24 Price Target | MT |
Mar. 18 | Olema Pharmaceuticals, Inc.(NasdaqGS:OLMA) added to S&P Biotechnology Select Industry Index | CI |
Financials (USD)
Sales 2024 * | - | Sales 2025 * | - | Capitalization | 557M |
---|---|---|---|---|---|
Net income 2024 * | -134M | Net income 2025 * | -163M | EV / Sales 2024 * | - |
Net cash position 2024 * | 96M | Net cash position 2025 * | 107M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-4.11
x | P/E ratio 2025 * |
-3.72
x | Employees | 74 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 95.88% |
Latest transcript on Olema Pharmaceuticals, Inc.
1 day | +1.22% | ||
1 week | +0.20% | ||
Current month | -12.10% | ||
1 month | -11.16% | ||
3 months | -10.84% | ||
6 months | -23.99% | ||
Current year | -29.08% |
Managers | Title | Age | Since |
---|---|---|---|
Peter Kushner
FOU | Founder | 86 | 06-08-06 |
Sean Bohen
CEO | Chief Executive Officer | 58 | 20-08-31 |
Cyrus Harmon
FOU | Founder | 54 | 06-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Clark
CHM | Chairman | 62 | 20-07-31 |
J. Garland
BRD | Director/Board Member | 55 | 23-10-15 |
Andy Rappaport
BRD | Director/Board Member | 66 | 12-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.59% | 4 M€ | -5.15% | - | |
0.01% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +2.14% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-26 | 9.95 | +1.22% | 434,481 |
24-04-25 | 9.83 | -3.15% | 1,281,773 |
24-04-24 | 10.15 | +1.50% | 546,692 |
24-04-23 | 10 | +1.32% | 575,233 |
24-04-22 | 9.87 | -0.60% | 806,213 |
Delayed Quote Nasdaq, April 26, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-29.08% | 557M | |
+1.51% | 42.75B | |
+49.22% | 41.61B | |
+8.57% | 41.34B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |
- Stock Market
- Equities
- OLMA Stock